|
long-range projecting sst GABAergic cortical interneuron (Mmus)
|
CL_4023025 |
[A sst GABAergic cortical interneuron that is both an interneuron and a projecting neuron. They are found in all layers from upper L2/3 down to the bottom of L6. They have long-range projections, some with axons fading into white matter. These cells have low rebound potential, low hyperpolarization sag, and high variability in membrane time constant.] |
|
mitotic interphase
|
GO_0051329 |
[The cell cycle phase following cytokinesis which begins with G1 phase, proceeds through S phase and G2 phase and ends when mitotic prophase begins. During interphase the cell readies itself for mitosis and the replication of its DNA occurs.] |
|
interphase
|
GO_0051325 |
[The cell cycle phase following cytokinesis which begins with G1 phase, proceeds through S phase and G2 phase and ends when prophase of meiosis or mitosis begins. During interphase the cell readies itself for meiosis or mitosis and the replication of its DNA occurs.] |
|
L5 non-Martinotti sst GABAergic cortical interneuron (Mmus)
|
CL_4023028 |
[A sst GABAergic cortical interneuron with a soma found in lower L5 with mostly local axonal arborization but with some sparse ascending axons. L5 non-Martinotti sst cells show somatic localization and local axon plexus in L5b and L5b/6 and substantial innervation of L3 and L4, and receive thalamic input from the ventral posteromedial nucleus and specifically target L4 neurons, avoiding L5 pyramidal cells. L5 non-Martinotti sst cells tend to show a higher input resistance and seem to be less stuttering.] |
|
L5 T-Martinotti sst GABAergic cortical interneuron (Mmus)
|
CL_4023027 |
[A sst GABAergic cortical interneuron with a soma found in L5 and possesses 'T-shaped' Martinotti morphologies with local axonal plexus in L5a and translaminar axons restricted to the uppermost part of L1. They show low-threshold spiking patterns with strong rebound firing, and inhibit the L1 apical tuft of nearby pyramidal cells.] |
|
indirect pathway medium spiny neuron
|
CL_4023029 |
[A medium spiny neuron that expresses dopamine type 2 receptors and projects to the external globus pallidus.] |
|
onium compound
|
CHEBI_50312 |
|
|
sphenovomerine suture
|
UBERON_7500107 |
[A suture joining a sphenoid bone with the alae of a vomer to form a schindylesis type of joint.] |
|
regulation of RNA metabolic process
|
GO_0051252 |
[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving RNA.] |
|
intersphenoid suture
|
UBERON_7500111 |
[A suture joining the basisphenoid bone and the presphenoid bone of a sphenoid bone.] |
|
cyclic organic group
|
CHEBI_52845 |
[An organic group that consists of a closed ring. It may be a substituent or a skeleton.] |
|
kidney blood vessel cell
|
CL_1000854 |
|
|
kidney blood vessel
|
UBERON_0003517 |
[A blood vessel that is part of a kidney [Automatically generated definition].] |
|
macula densa epithelial cell
|
CL_1000850 |
|
|
epithelial cell of distal tubule
|
CL_0002305 |
[An epithelial cell of the distal convoluted tubule of the kidney that helps regulate systemic levels of potassium, sodium, calcium, and pH.] |
|
macrophage mannose receptor 1 (human)
|
PR_P22897 |
[A macrophage mannose receptor 1 that is encoded in the genome of human.] |
|
NK T cell proliferation involved in immune response
|
GO_0002289 |
[The expansion of a NK T cell population by cell division as part of an immune response.] |
|
myeloid dendritic cell differentiation involved in immune response
|
GO_0002284 |
[The process in which an immature myeloid dendritic cell acquires the specialized features of a mature myeloid dendritic cell as part of an immune response.] |
|
myeloid dendritic cell activation involved in immune response
|
GO_0002277 |
[The change in morphology and behavior of a myeloid dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.] |
|
myeloid cell activation involved in immune response
|
GO_0002275 |
[A change in the morphology or behavior of a myeloid cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.] |